
Genome editing, or genome engineering, or gene editing, is a type of genetic engineering in which DNA is inserted, deleted, modified or replaced in the genome of a living organism.
Market Analysis and Insights: Global Gene Editing Service Market
The global Gene Editing Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Gene Editing Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Gene Editing Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Gene Editing Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Gene Editing Service include Caribou Biosciences, CRISPR Therapeutics, Merck KGaA, Editas Medicine, Thermo Fisher Scientific, Horizon Discovery, Genscript Biotech, GeneCopoeia and Integrated DNA Technologies, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Gene Editing Service is widely used in various fields, such as Commercial and Academic Research, etc. Commercial provides greatest supports to the Gene Editing Service industry development. In 2023, global % revenue of Gene Editing Service went into Commercial filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Gene Editing Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Gene Editing Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gene Editing Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gene Editing Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gene Editing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Gene Editing Service revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Caribou Biosciences
CRISPR Therapeutics
Merck KGaA
Editas Medicine
Thermo Fisher Scientific
Horizon Discovery
Genscript Biotech
GeneCopoeia
Integrated DNA Technologies
Eurofins Genomics
DNA 2.0 (ATUM)
BBI Life Sciences
Genewiz
Gene Oracle
SBS Genetech
Bio Basic
Segment by Type
Ex-Vivo
In-Vivo
Segment by Application
Commercial
Academic Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gene Editing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Editing Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Editing Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Editing Service Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Ex-Vivo
1.2.3 In-Vivo
1.3 Market by Application
1.3.1 Global Gene Editing Service Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Editing Service Market Perspective (2019-2030)
2.2 Global Gene Editing Service Growth Trends by Region
2.2.1 Gene Editing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Editing Service Historic Market Size by Region (2019-2024)
2.2.3 Gene Editing Service Forecasted Market Size by Region (2025-2030)
2.3 Gene Editing Service Market Dynamics
2.3.1 Gene Editing Service Industry Trends
2.3.2 Gene Editing Service Market Drivers
2.3.3 Gene Editing Service Market Challenges
2.3.4 Gene Editing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Gene Editing Service by Players
3.1.1 Global Gene Editing Service Revenue by Players (2019-2024)
3.1.2 Global Gene Editing Service Revenue Market Share by Players (2019-2024)
3.2 Global Gene Editing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Gene Editing Service, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Gene Editing Service Market Concentration Ratio
3.4.1 Global Gene Editing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Service Revenue in 2023
3.5 Global Key Players of Gene Editing Service Head office and Area Served
3.6 Global Key Players of Gene Editing Service, Product and Application
3.7 Global Key Players of Gene Editing Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Editing Service Breakdown Data by Type
4.1 Global Gene Editing Service Historic Market Size by Type (2019-2024)
4.2 Global Gene Editing Service Forecasted Market Size by Type (2025-2030)
5 Gene Editing Service Breakdown Data by Application
5.1 Global Gene Editing Service Historic Market Size by Application (2019-2024)
5.2 Global Gene Editing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Editing Service Market Size (2019-2030)
6.2 North America Gene Editing Service Market Size by Type
6.2.1 North America Gene Editing Service Market Size by Type (2019-2024)
6.2.2 North America Gene Editing Service Market Size by Type (2025-2030)
6.2.3 North America Gene Editing Service Market Share by Type (2019-2030)
6.3 North America Gene Editing Service Market Size by Application
6.3.1 North America Gene Editing Service Market Size by Application (2019-2024)
6.3.2 North America Gene Editing Service Market Size by Application (2025-2030)
6.3.3 North America Gene Editing Service Market Share by Application (2019-2030)
6.4 North America Gene Editing Service Market Size by Country
6.4.1 North America Gene Editing Service Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Gene Editing Service Market Size by Country (2019-2024)
6.4.3 North America Gene Editing Service Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Gene Editing Service Market Size (2019-2030)
7.2 Europe Gene Editing Service Market Size by Type
7.2.1 Europe Gene Editing Service Market Size by Type (2019-2024)
7.2.2 Europe Gene Editing Service Market Size by Type (2025-2030)
7.2.3 Europe Gene Editing Service Market Share by Type (2019-2030)
7.3 Europe Gene Editing Service Market Size by Application
7.3.1 Europe Gene Editing Service Market Size by Application (2019-2024)
7.3.2 Europe Gene Editing Service Market Size by Application (2025-2030)
7.3.3 Europe Gene Editing Service Market Share by Application (2019-2030)
7.4 Europe Gene Editing Service Market Size by Country
7.4.1 Europe Gene Editing Service Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Gene Editing Service Market Size by Country (2019-2024)
7.4.3 Europe Gene Editing Service Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Gene Editing Service Market Size (2019-2030)
8.2 China Gene Editing Service Market Size by Type
8.2.1 China Gene Editing Service Market Size by Type (2019-2024)
8.2.2 China Gene Editing Service Market Size by Type (2025-2030)
8.2.3 China Gene Editing Service Market Share by Type (2019-2030)
8.3 China Gene Editing Service Market Size by Application
8.3.1 China Gene Editing Service Market Size by Application (2019-2024)
8.3.2 China Gene Editing Service Market Size by Application (2025-2030)
8.3.3 China Gene Editing Service Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Gene Editing Service Market Size (2019-2030)
9.2 Asia Gene Editing Service Market Size by Type
9.2.1 Asia Gene Editing Service Market Size by Type (2019-2024)
9.2.2 Asia Gene Editing Service Market Size by Type (2025-2030)
9.2.3 Asia Gene Editing Service Market Share by Type (2019-2030)
9.3 Asia Gene Editing Service Market Size by Application
9.3.1 Asia Gene Editing Service Market Size by Application (2019-2024)
9.3.2 Asia Gene Editing Service Market Size by Application (2025-2030)
9.3.3 Asia Gene Editing Service Market Share by Application (2019-2030)
9.4 Asia Gene Editing Service Market Size by Region
9.4.1 Asia Gene Editing Service Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Gene Editing Service Market Size by Region (2019-2024)
9.4.3 Asia Gene Editing Service Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Gene Editing Service Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Gene Editing Service Market Size by Type
10.2.1 Middle East, Africa, and Latin America Gene Editing Service Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Gene Editing Service Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Gene Editing Service Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Gene Editing Service Market Size by Application
10.3.1 Middle East, Africa, and Latin America Gene Editing Service Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Gene Editing Service Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Gene Editing Service Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Gene Editing Service Market Size by Country
10.4.1 Middle East, Africa, and Latin America Gene Editing Service Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Gene Editing Service Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Gene Editing Service Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Details
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences Gene Editing Service Introduction
11.1.4 Caribou Biosciences Revenue in Gene Editing Service Business (2019-2024)
11.1.5 Caribou Biosciences Recent Developments
11.2 CRISPR Therapeutics
11.2.1 CRISPR Therapeutics Company Details
11.2.2 CRISPR Therapeutics Business Overview
11.2.3 CRISPR Therapeutics Gene Editing Service Introduction
11.2.4 CRISPR Therapeutics Revenue in Gene Editing Service Business (2019-2024)
11.2.5 CRISPR Therapeutics Recent Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Gene Editing Service Introduction
11.3.4 Merck KGaA Revenue in Gene Editing Service Business (2019-2024)
11.3.5 Merck KGaA Recent Developments
11.4 Editas Medicine
11.4.1 Editas Medicine Company Details
11.4.2 Editas Medicine Business Overview
11.4.3 Editas Medicine Gene Editing Service Introduction
11.4.4 Editas Medicine Revenue in Gene Editing Service Business (2019-2024)
11.4.5 Editas Medicine Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Gene Editing Service Introduction
11.5.4 Thermo Fisher Scientific Revenue in Gene Editing Service Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Developments
11.6 Horizon Discovery
11.6.1 Horizon Discovery Company Details
11.6.2 Horizon Discovery Business Overview
11.6.3 Horizon Discovery Gene Editing Service Introduction
11.6.4 Horizon Discovery Revenue in Gene Editing Service Business (2019-2024)
11.6.5 Horizon Discovery Recent Developments
11.7 Genscript Biotech
11.7.1 Genscript Biotech Company Details
11.7.2 Genscript Biotech Business Overview
11.7.3 Genscript Biotech Gene Editing Service Introduction
11.7.4 Genscript Biotech Revenue in Gene Editing Service Business (2019-2024)
11.7.5 Genscript Biotech Recent Developments
11.8 GeneCopoeia
11.8.1 GeneCopoeia Company Details
11.8.2 GeneCopoeia Business Overview
11.8.3 GeneCopoeia Gene Editing Service Introduction
11.8.4 GeneCopoeia Revenue in Gene Editing Service Business (2019-2024)
11.8.5 GeneCopoeia Recent Developments
11.9 Integrated DNA Technologies
11.9.1 Integrated DNA Technologies Company Details
11.9.2 Integrated DNA Technologies Business Overview
11.9.3 Integrated DNA Technologies Gene Editing Service Introduction
11.9.4 Integrated DNA Technologies Revenue in Gene Editing Service Business (2019-2024)
11.9.5 Integrated DNA Technologies Recent Developments
11.10 Eurofins Genomics
11.10.1 Eurofins Genomics Company Details
11.10.2 Eurofins Genomics Business Overview
11.10.3 Eurofins Genomics Gene Editing Service Introduction
11.10.4 Eurofins Genomics Revenue in Gene Editing Service Business (2019-2024)
11.10.5 Eurofins Genomics Recent Developments
11.11 DNA 2.0 (ATUM)
11.11.1 DNA 2.0 (ATUM) Company Details
11.11.2 DNA 2.0 (ATUM) Business Overview
11.11.3 DNA 2.0 (ATUM) Gene Editing Service Introduction
11.11.4 DNA 2.0 (ATUM) Revenue in Gene Editing Service Business (2019-2024)
11.11.5 DNA 2.0 (ATUM) Recent Developments
11.12 BBI Life Sciences
11.12.1 BBI Life Sciences Company Details
11.12.2 BBI Life Sciences Business Overview
11.12.3 BBI Life Sciences Gene Editing Service Introduction
11.12.4 BBI Life Sciences Revenue in Gene Editing Service Business (2019-2024)
11.12.5 BBI Life Sciences Recent Developments
11.13 Genewiz
11.13.1 Genewiz Company Details
11.13.2 Genewiz Business Overview
11.13.3 Genewiz Gene Editing Service Introduction
11.13.4 Genewiz Revenue in Gene Editing Service Business (2019-2024)
11.13.5 Genewiz Recent Developments
11.14 Gene Oracle
11.14.1 Gene Oracle Company Details
11.14.2 Gene Oracle Business Overview
11.14.3 Gene Oracle Gene Editing Service Introduction
11.14.4 Gene Oracle Revenue in Gene Editing Service Business (2019-2024)
11.14.5 Gene Oracle Recent Developments
11.15 SBS Genetech
11.15.1 SBS Genetech Company Details
11.15.2 SBS Genetech Business Overview
11.15.3 SBS Genetech Gene Editing Service Introduction
11.15.4 SBS Genetech Revenue in Gene Editing Service Business (2019-2024)
11.15.5 SBS Genetech Recent Developments
11.16 Bio Basic
11.16.1 Bio Basic Company Details
11.16.2 Bio Basic Business Overview
11.16.3 Bio Basic Gene Editing Service Introduction
11.16.4 Bio Basic Revenue in Gene Editing Service Business (2019-2024)
11.16.5 Bio Basic Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Caribou Biosciences
CRISPR Therapeutics
Merck KGaA
Editas Medicine
Thermo Fisher Scientific
Horizon Discovery
Genscript Biotech
GeneCopoeia
Integrated DNA Technologies
Eurofins Genomics
DNA 2.0 (ATUM)
BBI Life Sciences
Genewiz
Gene Oracle
SBS Genetech
Bio Basic
Ìý
Ìý
*If Applicable.
